P474: Applying the 2022 guidelines for non-coding variant classification in a large rare disease cohort

Bibliographic Details
Main Authors: Emily Groopman, Moriel Singer-Berk, Nicola Whiffin, Jamie Ellingford, Samantha Baxter, Heidi Rehm, Anne O’Donnell-Luria
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Genetics in Medicine Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2949774423005216
_version_ 1797341960508276736
author Emily Groopman
Moriel Singer-Berk
Nicola Whiffin
Jamie Ellingford
Samantha Baxter
Heidi Rehm
Anne O’Donnell-Luria
author_facet Emily Groopman
Moriel Singer-Berk
Nicola Whiffin
Jamie Ellingford
Samantha Baxter
Heidi Rehm
Anne O’Donnell-Luria
author_sort Emily Groopman
collection DOAJ
first_indexed 2024-03-08T10:26:31Z
format Article
id doaj.art-5483b6c48b7242fe8212b5ed78e2b389
institution Directory Open Access Journal
issn 2949-7744
language English
last_indexed 2024-03-08T10:26:31Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Genetics in Medicine Open
spelling doaj.art-5483b6c48b7242fe8212b5ed78e2b3892024-01-27T07:08:55ZengElsevierGenetics in Medicine Open2949-77442023-01-0111100521P474: Applying the 2022 guidelines for non-coding variant classification in a large rare disease cohortEmily Groopman0Moriel Singer-Berk1Nicola Whiffin2Jamie Ellingford3Samantha Baxter4Heidi Rehm5Anne O’Donnell-Luria6Broad Institute of MIT and Harvard, Cambridge, MA; Boston Children’s Hospital, Boston, MA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MABroad Institute of MIT and Harvard, Cambridge, MA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MAWellcome Centre for Human Genetics at the University of Oxford, Oxford, UKDivision of Evolution, Infection and Genomic Sciences, School of Biological Sciences, Biology, Medicines and Health, University of Manchester, Manchester, UKBroad Institute of MIT and Harvard, Cambridge, MA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MABroad Institute of MIT and Harvard, Cambridge, MA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MABroad Institute of MIT and Harvard, Cambridge, MA; Boston Children’s Hospital, Boston, MA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MAhttp://www.sciencedirect.com/science/article/pii/S2949774423005216
spellingShingle Emily Groopman
Moriel Singer-Berk
Nicola Whiffin
Jamie Ellingford
Samantha Baxter
Heidi Rehm
Anne O’Donnell-Luria
P474: Applying the 2022 guidelines for non-coding variant classification in a large rare disease cohort
Genetics in Medicine Open
title P474: Applying the 2022 guidelines for non-coding variant classification in a large rare disease cohort
title_full P474: Applying the 2022 guidelines for non-coding variant classification in a large rare disease cohort
title_fullStr P474: Applying the 2022 guidelines for non-coding variant classification in a large rare disease cohort
title_full_unstemmed P474: Applying the 2022 guidelines for non-coding variant classification in a large rare disease cohort
title_short P474: Applying the 2022 guidelines for non-coding variant classification in a large rare disease cohort
title_sort p474 applying the 2022 guidelines for non coding variant classification in a large rare disease cohort
url http://www.sciencedirect.com/science/article/pii/S2949774423005216
work_keys_str_mv AT emilygroopman p474applyingthe2022guidelinesfornoncodingvariantclassificationinalargerarediseasecohort
AT morielsingerberk p474applyingthe2022guidelinesfornoncodingvariantclassificationinalargerarediseasecohort
AT nicolawhiffin p474applyingthe2022guidelinesfornoncodingvariantclassificationinalargerarediseasecohort
AT jamieellingford p474applyingthe2022guidelinesfornoncodingvariantclassificationinalargerarediseasecohort
AT samanthabaxter p474applyingthe2022guidelinesfornoncodingvariantclassificationinalargerarediseasecohort
AT heidirehm p474applyingthe2022guidelinesfornoncodingvariantclassificationinalargerarediseasecohort
AT anneodonnellluria p474applyingthe2022guidelinesfornoncodingvariantclassificationinalargerarediseasecohort